PREFORMULATION STUDIES IN A DRUG DEVELOPMENT PROGRAM FOR TABLET FORMULATIONS

被引：12

作者：

GRAFFNER, C

JOHANSSON, ME

NICKLASSON, M

NYQVIST, H

机构：

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 1985年 / 74卷 / 01期

关键词：

D O I：

10.1002/jps.2600740105

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：16 / 20

页数：5

共 21 条

[1]

AKERS MJ, 1976, CAN J PHARM SCI, V11, P1

[2] PHARMACEUTICAL SALTS [J].

BERGE, SM ;

BIGHLEY, LD ;

MONKHOUSE, DC .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (01) :1-19

[3]

COLLETT JH, 1976, PHARM ACTA HELV, V51, P27

[4]

DEPAULIS T, IN PRESS

[5] POTENTIAL NEUROLEPTIC AGENTS - 2,6-DIALKOXYBENZAMIDE DERIVATIVES WITH POTENT DOPAMINE RECEPTOR BLOCKING ACTIVITIES [J].

FLORVALL, L ;

OGREN, SO .

JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (11) :1280-1286

[6]

GUYOT JC, 1978, INT C POWDER TECHNOL

[7] RELATIONSHIP BETWEEN IN VITRO DISSOLUTION RATES AND SOLUBILITIES OF NUMEROUS COMPOUNDS REPRESENTATIVE OF VARIOUS CHEMICAL SPECIES [J].

HAMLIN, WE ;

NORTHAM, JI ;

WAGNER, JG .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1965, 54 (11) :1651-&

[8] FENOPROFEN - DRUG FORM SELECTION AND PRE-FORMULATION STABILITY STUDIES [J].

HIRSCH, CA ;

MESSENGER, RJ ;

BRANNON, JL .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (02) :231-236

[9]

HUMBERTDROZ P, 1982, PHARM ACTA HELV, V57, P136

[10]

JONES TM, 1978, ACTA PHARM TECHNOL S, V6, P141

← 1 2 3 →